Delivery Order SPE2DX22D0010-SPE2D826FAW82
- Not listed
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $10,441.56 to AmerisourceBergen Drug Corp for Nucynta Tabs 50mg on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- AmerisourceBergen Drug Corp was awarded a delivery order for Nucynta ER Tabs 250mg valued at $12,666.01 by the Defense Department's Medical Supply Chain on October 28, 2025, with an ultimate completion date of October 29, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on October 6, 2025, for Nucynta ER Tabs 100mg with a ceiling value of $5,338.16. This firm fixed price delivery order, with an ultimate completion date of October 7, 2025, was competitively awarded without set-aside provisions to support the Defense Logistics Agency's Medical Supply Chain. The contract represents a continuation of AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Nucynta Tabs 50mg valued at $4,442.48 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain on October 23, 2025. The contract is non-competitive, non-set-aside, and represents a single delivery order with an ultimate completion date of October 24, 2025. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $4,442.48, is scheduled for completion by October 8, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's proven...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 22, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units). This competitively awarded, non-set-aside contract carries a ceiling value of $1,960.50 and is structured as a firm fixed price delivery order with an ultimate completion date of October 23, 2025. The contract represents a fulfillment...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $13,932.13 for Nucynta Tabs 75mg, a pain management pharmaceutical product. This firm fixed-price delivery order, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitive procurement with no set-aside designation. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,288.63 on July 25, 2025, for the supply of Nucynta Tabs 50mg under a firm fixed price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by July 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Nucynta Tabs 50mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $7,938.87, represents a non-competitive set-aside contract and is scheduled for completion by October 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 22, 2025, for Nucynta ER 250 mg tablets (60-count supply). The contract is valued at $1,460.09 with a firm fixed price structure and an ultimate completion date of October 23, 2025. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAW82Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,658.73 for Nucynta Tabs 50mg on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, firm fixed-price contract serves the Department of Defense's Medical Supply Chain and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle, reflecting the company's role as a critical pharmaceutical supplier to federal healthcare systems. This award falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The Defense Logistics Agency is transitioning to Pharmaceutical Prime Vendor Global Program Generation V contracts with plans for multiple regional awards, positioning AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible procurement mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.7k | 11/6/25 |